Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Vet Intern Med ; 2024 Jul 13.
Artigo em Inglês | MEDLINE | ID: mdl-39001675

RESUMO

BACKGROUND: Lymphoma has been implicated as a possible cause of proteinuria in dogs. However, information about the potential importance of proteinuria in dogs with lymphoma is limited. HYPOTHESIS: To determine if the presence of proteinuria at diagnosis was associated with median survival times in dogs with lymphoma and if lymphoma stage (I-V) or type (B vs T) were associated with the presence of proteinuria. ANIMALS: Eighty-six client-owned dogs with a new diagnosis of lymphoma between 2008 and 2020. METHODS: This was a retrospective cross-sectional study with dogs divided into proteinuric or nonproteinuric groups based on dipstick urine protein (protein ≥30 mg/dL classified as proteinuric) or a ratio of dipstick protein to urine specific gravity (ratio ≥1.5 classified as proteinuric). Dogs were excluded for: (1) treatment within 2 months with glucocorticoid, anti-neoplastic, or anti-proteinuric therapies, (2) diagnosed hypercortisolism or renal lymphoma, (3) active urine sediment, or (4) urine pH >8. Survival analysis utilized a Kaplan-Meier estimator and log-rank testing. RESULTS: There was a significant difference in median survival between proteinuric and nonproteinuric dogs classified by urine dipstick (245 days [91, 399] vs 335 days [214, 456]; P = .03) or UP : USG (237 days [158, 306] vs 304 days [173, 434]; P = .03). No difference in prevalence of proteinuria was identified between stages (I-V) or types (B and T). CONCLUSIONS AND CLINICAL IMPORTANCE: Proteinuria appears to be negatively associated with survival time in dogs newly diagnosed with lymphoma.

2.
J Vet Intern Med ; 38(2): 1068-1073, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38348890

RESUMO

BACKGROUND: Ammonium excretion decreases as kidney function decreases in several species, including cats, and may have predictive or prognostic value in patients with chronic kidney disease (CKD). Urine ammonia measurement is not readily available in clinical practice, and urine anion gap (UAG) has been proposed as a surrogate test. OBJECTIVES: Evaluate the correlation between urine ammonia-to-creatinine ratio (UACR) and UAG in healthy cats and those with CKD and determine if a significant difference exists between UAG of healthy cats and cats with CKD. ANIMALS: Urine samples collected from healthy client-owned cats (n = 59) and those with stable CKD (n = 17). METHODS: Urine electrolyte concentrations were measured using a commercial chemistry analyzer and UAG was calculated as ([sodium] + [potassium]) - [chloride]. Urine ammonia and creatinine concentrations had been measured previously using commercially available enzymatic assays and used to calculate UACR. Spearman's rank correlation coefficient between UAG and UACR was calculated for both groups. The UAG values of healthy cats and cats with CKD were assessed using the Mann-Whitney test (P < .05). RESULTS: The UAG was inversely correlated with UACR in healthy cats (P < .002, r0 = -0.40) but not in cats with CKD (P = .55; r0 = -0.15). A significant difference was found between UAG in healthy cats and those with CKD (P < .001). CONCLUSIONS AND CLINICAL IMPORTANCE: The UAG calculation cannot be used as a substitute for UACR in cats. The clinical relevance of UAG differences between healthy cats and those with CKD remains unknown.


Assuntos
Doenças do Gato , Insuficiência Renal Crônica , Humanos , Gatos , Animais , Equilíbrio Ácido-Base , Creatinina/urina , Amônia , Insuficiência Renal Crônica/urina , Insuficiência Renal Crônica/veterinária , Prognóstico
3.
Vet Clin Pathol ; 53(1): 136-140, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38321630

RESUMO

BACKGROUND: Disruption of acid-base homeostasis can lead to many clinical problems. Ammonia excretion by the kidneys is critical to maintaining acid-base homeostasis through bicarbonate production. Measurement of ammonia excretion may help determine if the kidneys are properly functioning in maintaining acid-base balance. Reference intervals are essential tools for clinical decision-making but do not currently exist for urinary ammonia-to-creatinine ratio (UACR) in feline patients. OBJECTIVE: This study aimed to generate a reference interval (RI) for UACR in healthy adult cats. METHODS: The study used samples from client-owned adult healthy cats that presented to the University of Florida Primary Care and Dentistry service (n = 92). Physical examination, serum biochemistry, urinalysis, urine ammonia, and creatinine concentrations were measured. Cats were excluded if there were significant abnormalities in their urinalysis or biochemistry panel. The RI for UACR was calculated according to the recommendation of the American Society for Veterinary Clinical Pathology. The UACR was evaluated for correlation with serum bicarbonate, weight, age, and sex. RESULTS: The RI for UACR was 3.4-20.7 with 90% confidence intervals for the lower and upper limits of (3.0-3.7) and (16.0-23.7), respectively. No significant correlation with age, sex, or weight was found. There was no discernable relationship between serum bicarbonate and UACR. CONCLUSIONS: Establishing an RI for UACR in healthy adult cats will allow further studies to determine if changes in UACR are observed during specific disease states.


Assuntos
Amônia , Doenças do Gato , Gatos , Animais , Creatinina/urina , Bicarbonatos , Urinálise/veterinária , Rim , Albuminúria/urina , Albuminúria/veterinária
4.
J Vet Emerg Crit Care (San Antonio) ; 33(2): 247-256, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-36573353

RESUMO

OBJECTIVE: To describe the therapeutic protocol used to normalize severe hypertriglyceridemia in a dog. CASE SUMMARY: A 7-month-old, 1.2-kg female Pomeranian presented with acute polyuria, polydipsia, and ocular discoloration. Diagnoses included diabetic ketosis, severe hypertriglyceridemia (>225 mmol/L [>20,000 mg/dl]), lipemia retinalis, and bilateral uveitis. The triglyceride concentration was near normal within 2 days of initiating treatment with fenofibrate, regular insulin constant rate infusion (CRI), manual therapeutic plasma exchange (TPE), and a low-fat diet. All clinical signs resolved. The dog has had no relapse of hypertriglyceridemia at the time of writing the manuscript, 6 months later, with continued treatment of diabetes mellitus. NEW OR UNIQUE INFORMATION PROVIDED: This is the first case report documenting the combination of fenofibrate, insulin CRI, and manual TPE for treatment of severe hyperlipidemia in a dog. Detailed protocols for manual TPE and a novel insulin CRI are provided. A discussion of multiple spurious biochemical and hematologic errors associated with the severe hypertriglyceridemia is also provided.


Assuntos
Diabetes Mellitus , Cetoacidose Diabética , Doenças do Cão , Fenofibrato , Hiperlipidemias , Hipertrigliceridemia , Cães , Feminino , Animais , Fenofibrato/uso terapêutico , Hipertrigliceridemia/complicações , Hipertrigliceridemia/terapia , Hipertrigliceridemia/veterinária , Hiperlipidemias/complicações , Hiperlipidemias/veterinária , Insulina/uso terapêutico , Cetoacidose Diabética/terapia , Cetoacidose Diabética/veterinária , Terapia Combinada/veterinária , Diabetes Mellitus/terapia , Diabetes Mellitus/veterinária , Doenças do Cão/etiologia , Doenças do Cão/terapia
5.
J Vet Intern Med ; 36(5): 1628-1640, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-36053877

RESUMO

BACKGROUND: Sampling from a peripheral intravenous catheter (PIVC) might be a more efficient and less traumatic collection of blood for serum biochemistry (SB) or CBC than direct venipuncture (DV). Agreement between results of samples obtained by these methods has not been evaluated in dogs. OBJECTIVES: The primary objectives were to determine whether sampling from PIVC could be used in place of DV for dogs. We hypothesized DV and PIVC samples would have clinically equivalent SB and CBC results. ANIMALS: Sixty-one client-owned dogs were included in each study arm. METHODS: This was a partially randomized method-comparison study. Paired DV and PIVC samples obtained within 1 to 2 minutes after, or approximately 24 hours after, placement of a PIVC in a cephalic vein were evaluated for agreement and bias using percentage difference plots (with a priori application of consensus total allowable error), Bland-Altman analysis, Passing-Bablok regression analysis, Wilcoxon signed rank test, and McNemar's test. RESULTS: There was statistically and clinically acceptable agreement and no bias between sampling methods for the majority of results. Analytes with the most frequent disagreement were aspartate aminotransferase, total bilirubin, potassium, bicarbonate, and leukocyte differential counts, as well as red blood cell count, hemoglobin, hematocrit, and packed cell volume in the hospitalized PIVC sampling group. Few observed differences would change clinical decision making. CONCLUSIONS AND CLINICAL IMPORTANCE: PIVC sampling can provide generally acceptable SB and CBC results for most dogs, but clinicians should be aware of a few values for which disparate results might occasionally be obtained.


Assuntos
Bicarbonatos , Flebotomia , Animais , Aspartato Aminotransferases , Bilirrubina , Catéteres , Cães , Hemoglobinas , Flebotomia/métodos , Flebotomia/veterinária , Potássio
6.
Vet Ophthalmol ; 25(6): 468-475, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-35913421

RESUMO

OBJECTIVE: This study served to compare the degree of adrenocortical suppression following a 2-week administration of loteprednol etabonate (LE) and prednisolone acetate (PA) ophthalmic drops. PROCEDURES: In this prospective double-masked triple-crossover study, 21 clinically healthy dogs were randomized to receive loteprednol etabonate ophthalmic suspension 0.5%, prednisolone acetate ophthalmic suspension 1%, or artificial tears (AT). Each group (LE, PA, and AT) received one drop in each eye every 12 h for 2 weeks, followed by a 3-week washout period between treatment blocks. ACTH stimulation tests were performed before and after each treatment block. Serum cortisol samples were drawn before and 60 min after administration of 1 µg/kg cosyntropin IV. Repeated-measurement ANOVA followed by a Tukey's multiple comparisons test (or a Friedman test followed by a Dunn's multiple comparisons test) were used to compare pre- and post-treatment cortisol values between each group. A p-value of ≤.05 was considered significant. RESULTS: A total of 18 dogs completed the study. Prestimulation cortisol values were lower in the PA group compared to the LE (p = .0106), but not AT (p = .0589) groups, and post-stimulation cortisol values were lower in the PA group than either LE (p = .0005) or AT (p = .0002) groups. There was no significant difference detected in pre- or post-stimulation cortisol values after the treatment periods between LE and AT. CONCLUSIONS: Based on the reduced suppression of cortisol values, LE caused significantly less hypothalamic-pituitary-adrenal axis suppression than PA. A topical steroid with minimal adrenocortical suppression, such as LE, may be favorable in patients where systemic glucocorticoid effects should be avoided.


Assuntos
Hidrocortisona , Sistema Hipotálamo-Hipofisário , Cães , Animais , Etabonato de Loteprednol , Estudos Prospectivos , Estudos Cross-Over , Androstadienos/efeitos adversos , Sistema Hipófise-Suprarrenal , Soluções Oftálmicas/efeitos adversos , Hormônio Adrenocorticotrópico/farmacologia
7.
Vet Clin Pathol ; 50(4): 597-602, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34854107

RESUMO

BACKGROUND: Ammonia is produced and excreted by the kidney, contributing to systemic acid-base homeostasis through the production of bicarbonate. Disorders of acid-base balance can lead to many clinical problems and measuring ammonia excretion helps in determining if the kidneys are responding to acid-base challenges appropriately. Reference intervals are integral to clinical decision-making, and there is no current RI for the urine ammonia-to-creatinine ratio (UACR) in dogs. OBJECTIVE: This study aimed to generate an RI for the UACR in healthy adult dogs. METHODS: The study used adult, client-owned dogs that were presented to the University of Florida Primary Care and Dentistry service (n = 60). Physical examinations were performed and serum chemistry and urinalysis samples were obtained. Urine ammonia and creatinine concentrations were determined. Dogs were excluded if there were significant abnormalities in either their urinalysis or serum chemistry results. The RI for the UACR was calculated according to the recommendation of the American Society for Veterinary Clinical Pathology. Data were evaluated for correlation with serum bicarbonate, weight, age, and sex. RESULTS: The RIs for the UACR were 0.16-23.69 with 90% confidence intervals for the lower and upper limits of (0.13-1.17) and (20.50-23.75), respectively. No significant impact of age, sex, or weight was found. There was no discernable relationship between serum bicarbonate and UACR. CONCLUSIONS: Establishing an RI for UACR in healthy adult dogs will allow for further studies to determine if alterations are observed during specific disease states.


Assuntos
Amônia , Urinálise , Animais , Creatinina , Cães , Rim , Valores de Referência , Urinálise/veterinária
8.
J Vet Intern Med ; 32(5): 1652-1658, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-30221795

RESUMO

BACKGROUND: Preanalytic protein adsorption to polymer and glass container surfaces may decrease urine protein concentration measurements and urine protein: creatinine ratios (UPC). HYPOTHESIS/OBJECTIVES: Urine stored in PC or glass containers will have lower UPC than urine stored in HP containers. The specific objective was to determine whether clinically relevant differences in UPC would be detected after storage in glass, PC, or HP containers using common storage times and temperatures. ANIMALS: Twelve client-owned dogs with proteinuria. METHODS: Prospective, nonmasked study, divided into 2 phases. The first phase was a pilot study involving multiple (n = 5) measurements at each storage condition using 24-hours urine samples from 2 dogs with persistent renal proteinuria of different magnitude. The second phase used urine samples from 10 dogs with proteinuria of variable magnitude. Sample aliquots were stored in HP, PC, and glass containers at 24°C for 4 hours, 4°C for 12 hours, and -20°C for 72 hours. The UPC of each was measured after storage and compared with baseline. RESULTS: Statistically significant but clinically irrelevant differences were found in phase 1. In phase 2, storage conditions did not affect urinary protein or creatinine concentrations or UPC. CONCLUSIONS AND CLINICAL IMPORTANCE: Collection and storage of canine urine samples in clean HP, PC, or glass containers at 24°C for 4 hours, 4°C for 12 hours, or -20°C for 72 hours is unlikely to result in clinically relevant decreases in measured UPC values.


Assuntos
Creatinina/urina , Doenças do Cão/urina , Proteinúria/veterinária , Urinálise/veterinária , Animais , Doenças do Cão/diagnóstico , Cães , Vidro , Manejo de Espécimes
9.
J Inherit Metab Dis ; 41(6): 977-984, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-29802554

RESUMO

BACKGROUND: Viral mediated gene therapy has progressed after overcoming early failures, and gene therapy has now been approved for several conditions in Europe and the USA. Glycogen storage disease (GSD) type Ia, caused by a deficiency of glucose-6-phosphatase-α, has been viewed as an outstanding candidate for gene therapy. This follow-up report describes the long-term outcome for the naturally occurring GSD-Ia dogs treated with rAAV-GPE-hG6PC-mediated gene therapy. METHODS: A total of seven dogs were treated with rAAV-GPE-hG6PC-mediated gene therapy. The first four dogs were treated at birth, and three dogs were treated between 2 and 6 months of age to assess the efficacy and safety in animals with mature livers. Blood and urine samples, radiographic studies, histological evaluation, and biodistribution were assessed. RESULTS: Gene therapy improved survival in the GSD-Ia dogs. With treatment, the biochemical studies normalized for the duration of the study (up to 7 years). None of the rAAV-GPE-hG6PC-treated dogs had focal hepatic lesions or renal abnormalities. Dogs treated at birth required a second dose of rAAV after 2-4 months; gene therapy after hepatic maturation resulted in improved efficacy after a single dose. CONCLUSION: rAAV-GPE-hG6PC treatment in GSD-Ia dogs was found to be safe and efficacious. GSD-Ia is an attractive target for human gene therapy since it is a monogenic disorder with limited tissue involvement. Blood glucose and lactate monitoring can be used to assess effectiveness and as a biomarker of success. GSD-Ia can also serve as a model for other hepatic monogenic disorders.


Assuntos
Terapia Genética/métodos , Doença de Depósito de Glicogênio Tipo I/terapia , Animais , Glicemia/metabolismo , Dependovirus/genética , Modelos Animais de Doenças , Cães , Europa (Continente) , Vetores Genéticos , Glucose-6-Fosfatase/genética , Hipoglicemia/genética , Hipoglicemia/metabolismo , Rim/metabolismo , Fígado/metabolismo
10.
Vet Ophthalmol ; 21(6): 652-660, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29482261

RESUMO

An approximately 2-year-old female Doberman Pinscher was referred for the evaluation of bilateral, chronic proliferative conjunctivitis. Ophthalmic examination revealed bilateral thick, opaque pseudomembranes originating from the conjunctivae that prevented visualization of the cornea and interior structures of the eye. Histopathological findings of biopsies of the pseudomembranes were consistent with ligneous conjunctivitis. Serum plasminogen activity levels were within the normal range. Treatment with topical and systemic anti-inflammatory and immunosuppressive drugs did not improve the conjunctival lesions. The pseudomembranes were surgically excised, and the conjunctival surfaces were reconstructed with amniotic membrane. At final re-examination two years postsurgery, there was no evidence of recurrence of the pseudomembranes. To the authors' knowledge, this is the first reported case of the successful treatment of canine ligneous conjunctivitis with amniotic membrane transplantation.


Assuntos
Âmnio/transplante , Conjuntivite/veterinária , Doenças do Cão/cirurgia , Animais , Túnica Conjuntiva/patologia , Túnica Conjuntiva/cirurgia , Conjuntivite/diagnóstico , Conjuntivite/patologia , Conjuntivite/cirurgia , Doenças do Cão/diagnóstico , Doenças do Cão/patologia , Cães , Feminino
11.
J Am Vet Med Assoc ; 251(1): 80-83, 2017 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-28621602

RESUMO

CASE DESCRIPTION A 3-year-old spayed female Bengal cat was evaluated because of a history of bilateral pleural effusion and hydronephrosis of the right kidney. CLINICAL FINDINGS Cytologic analysis of a pleural fluid sample revealed characteristics of a pure transudate with a high percentage of lymphocytes. Results of fluid biochemical testing were not consistent with urine or chyle. Serum biochemical analysis and echocardiography yielded no evidence of hypoalbuminemia or high hydrostatic pressure secondary to cardiac disease. Abdominal ultrasonography revealed hydronephrosis of the right kidney and hydroureter of the right ureter. TREATMENT AND OUTCOME Exploratory laparotomy with nephrectomy of the right kidney was performed. At the time of surgery, there was no evidence of communication between the retroperitoneal space and thoracic cavity. No other treatments were performed. No evidence of pleural fluid accumulation was detected 1 week after surgery, and no recurrence of clinical signs associated with pleural effusion was observed for > 1 year after surgery. CLINICAL RELEVANCE Transudative, or nonchylous lymphatic, pleural effusion secondary to intra-abdominal disease, but independent of a low plasma protein concentration, is uncommon in veterinary medicine. This case emphasized that urinary tract obstruction should be considered as a differential diagnosis for cats with pleural effusion when more common disorders are not identified. Even without evidence of direct communication between the abnormal kidney or retroperitoneal space and the pleural space, removal of the hydronephrotic kidney appeared curative.


Assuntos
Doenças do Gato/cirurgia , Hidronefrose/veterinária , Nefrectomia/veterinária , Derrame Pleural/veterinária , Animais , Gatos , Feminino , Hidronefrose/cirurgia , Nefrectomia/efeitos adversos , Derrame Pleural/etiologia
13.
J Am Anim Hosp Assoc ; 49(4): 286-92, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23690488

RESUMO

A severe increase in total bilirubin coincided with a decline in neurologic status to comatose in a 9 yr old spayed female mixed-breed dog being treated for immune-mediated hemolytic anemia. MRI of the brain was performed to investigate potential causes for the neurologic signs. MRI revealed bilaterally symmetrical hyperintensities within the caudate nuclei, globus pallidus, thalamus, deep cerebellar nuclei, and cortical gray matter on T2-weighted and fluid-attenuated inversion recovery (FLAIR) sequences, which coincided with areas of bilirubin deposition and neuronal necrosis (kernicterus) identified on necropsy examination. This is the second case report of an adult dog exhibiting kernicterus, and the first report to document MRI findings associated with that condition. Kernicterus is an uncommonly reported complication of hyperbilirubinemia in dogs, but is potentially underreported due to difficulties in recognizing subtle lesions and distinguishing kernicterus from other potential causes of neurologic abnormalities with readily available antemortem tests. MRI may be helpful in supporting the diagnosis of kernicterus.


Assuntos
Doenças do Cão/diagnóstico , Doenças do Cão/etiologia , Hiperbilirrubinemia/veterinária , Kernicterus/veterinária , Imageamento por Ressonância Magnética/veterinária , Animais , Encéfalo/patologia , Doenças do Cão/patologia , Cães , Evolução Fatal , Feminino , Hiperbilirrubinemia/complicações , Hiperbilirrubinemia/diagnóstico , Kernicterus/diagnóstico , Kernicterus/etiologia , Kernicterus/patologia
14.
J Am Anim Hosp Assoc ; 47(3): 151-60, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21498596

RESUMO

Iron is an essential element for nearly all living organisms and disruption of iron homeostasis can lead to a number of clinical manifestations. Iron is used in the formation of both hemoglobin and myoglobin, as well as numerous enzyme systems of the body. Disorders of iron in the body include iron deficiency anemia, anemia of inflammatory disease, and iron overload. This article reviews normal iron metabolism, disease syndromes of iron imbalance, diagnostic testing, and treatment of either iron deficiency or excess. Recent advances in diagnosing iron deficiency using reticulocyte indices are reviewed.


Assuntos
Doenças do Gato/metabolismo , Doenças do Cão/metabolismo , Homeostase/fisiologia , Distúrbios do Metabolismo do Ferro/veterinária , Ferro/metabolismo , Anemia Ferropriva/metabolismo , Anemia Ferropriva/veterinária , Animais , Gatos , Cães , Distúrbios do Metabolismo do Ferro/metabolismo , Sobrecarga de Ferro/metabolismo , Sobrecarga de Ferro/veterinária
15.
J Biomed Biotechnol ; 2011: 646257, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21318173

RESUMO

A canine model of Glycogen storage disease type Ia (GSDIa) is described. Affected dogs are homozygous for a previously described M121I mutation resulting in a deficiency of glucose-6-phosphatase-α. Metabolic, clinicopathologic, pathologic, and clinical manifestations of GSDIa observed in this model are described and compared to those observed in humans. The canine model shows more complete recapitulation of the clinical manifestations seen in humans including "lactic acidosis", larger size, and longer lifespan compared to other animal models. Use of this model in preclinical trials of gene therapy is described and briefly compared to the murine model. Although the canine model offers a number of advantages for evaluating potential therapies for GSDIa, there are also some significant challenges involved in its use. Despite these challenges, the canine model of GSDIa should continue to provide valuable information about the potential for generating curative therapies for GSDIa as well as other genetic hepatic diseases.


Assuntos
Modelos Animais de Doenças , Doenças do Cão/genética , Doenças do Cão/metabolismo , Doença de Depósito de Glicogênio Tipo I/genética , Doença de Depósito de Glicogênio Tipo I/metabolismo , Hepatopatias/genética , Hepatopatias/metabolismo , Animais , Ensaios Clínicos como Assunto , Cães , Doença de Depósito de Glicogênio Tipo I/diagnóstico , Doença de Depósito de Glicogênio Tipo I/patologia , Doença de Depósito de Glicogênio Tipo I/veterinária , Humanos , Hepatopatias/veterinária
17.
Hum Gene Ther ; 21(7): 903-10, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20163245

RESUMO

Glycogen storage disease type Ia (GSDIa; von Gierke disease; MIM 232200) is caused by a deficiency in glucose-6-phosphatase-alpha. Patients with GSDIa are unable to maintain glucose homeostasis and suffer from severe hypoglycemia, hepatomegaly, hyperlipidemia, hyperuricemia, and lactic acidosis. The canine model of GSDIa is naturally occurring and recapitulates almost all aspects of the human form of disease. We investigated the potential of recombinant adeno-associated virus (rAAV) vector-based therapy to treat the canine model of GSDIa. After delivery of a therapeutic rAAV2/8 vector to a 1-day-old GSDIa dog, improvement was noted as early as 2 weeks posttreatment. Correction was transient, however, and by 2 months posttreatment the rAAV2/8-treated dog could no longer sustain normal blood glucose levels after 1 hr of fasting. The same animal was then dosed with a therapeutic rAAV2/1 vector delivered via the portal vein. Two months after rAAV2/1 dosing, both blood glucose and lactate levels were normal at 4 hr postfasting. With more prolonged fasting, the dog still maintained near-normal glucose concentrations, but lactate levels were elevated by 9 hr, indicating that partial correction was achieved. Dietary glucose supplementation was discontinued starting 1 month after rAAV2/1 delivery and the dog continues to thrive with minimal laboratory abnormalities at 23 months of age (18 months after rAAV2/1 treatment). These results demonstrate that delivery of rAAV vectors can mediate significant correction of the GSDIa phenotype and that gene transfer may be a promising alternative therapy for this disease and other genetic diseases of the liver.


Assuntos
Dependovirus/genética , Terapia Genética , Vetores Genéticos , Doença de Depósito de Glicogênio Tipo I/terapia , Animais , Modelos Animais de Doenças , Cães , Vetores Genéticos/administração & dosagem , Doença de Depósito de Glicogênio Tipo I/genética , Humanos
18.
Vet Radiol Ultrasound ; 48(3): 199-203, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17508504

RESUMO

Tracheal collapse is common in middle age toy and miniature breed dogs. Cartilaginous defects have been identified histologically and are considered a form of chondromalacia. In addition to tracheal cartilaginous changes, concurrent lower airway histologic changes indicative of inflammation have been noted in dogs with tracheal collapse and these changes may lead t o concurrent bronchiectasis. The purpose of this study was to investigate the prevalence of bronchiectasis in dogs with a previous radiographic diagnosis of tracheal collapse. The thoracic radiographs of 60 dogs with tracheal collapse were evaluated for evidence of concurrent bronchiectasis. Eighteen of 60 (30%) dogs had evidence of bronchiectasis, and all were cylindrical in morphology. The signalment of affected dogs was similar to that previously reported. The occurrence of bronchiectasis in this group of dogs with tracheal collapse (18 dogs) was six times higher (P < 0.05) than the expected prevalence within a random sample population (three dogs). The results of this study provide evidence of a link between tracheal collapse and bronchiectasis. A finding of bronchiectasis with tracheal collapse should encourage further evaluation for chronic lower airway disease in these patients.


Assuntos
Bronquiectasia/veterinária , Doenças do Cão/diagnóstico por imagem , Radiografia Torácica/veterinária , Doenças da Traqueia/veterinária , Animais , Cruzamento , Bronquiectasia/diagnóstico por imagem , Bronquiectasia/epidemiologia , Bronquiectasia/etiologia , Doenças do Cão/epidemiologia , Cães , Feminino , Masculino , Radiografia Torácica/métodos , Estudos Retrospectivos , Traqueia/anormalidades , Traqueia/diagnóstico por imagem , Doenças da Traqueia/complicações , Doenças da Traqueia/diagnóstico por imagem , Doenças da Traqueia/epidemiologia
20.
Compend Contin Educ Vet ; 29(12): 733-43, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18225637

RESUMO

Small animal patients with endocrinopathies are at risk of developing many ophthalmic conditions resulting from endocrine hormone imbalances. Diabetic animals frequently develop cataracts but can also have numerous other ocular problems, including uveitis, keratopathy, retinopathy, and the effects of lipid derangements and systemic hypertension. Cushing's patients can develop complications from hyperlipidemia and hypertension and sometimes present with corneal disease. Acute blindness from sudden acquired retinal degeneration has been associated with disease of the pituitary-adrenal axis. Growth hormone disturbances can result in the secondary ocular effects of hypertension or of thyroid deficiency (e.g., corneal infiltrates, decreased tear production, neurologic dysfunction). Hyperthyroid animals can present with the ocular manifestations of systemic hypertension. Disorders of calcium homeostasis are unusual, typically manifesting as cataracts in hypocalcemic patients or as metastatic calcification of the ocular tissues.


Assuntos
Doenças dos Animais/diagnóstico , Doenças do Sistema Endócrino/veterinária , Oftalmopatias/veterinária , Animais , Diabetes Mellitus/veterinária , Diagnóstico Diferencial , Doenças do Sistema Endócrino/complicações , Doenças do Sistema Endócrino/diagnóstico , Oftalmopatias/diagnóstico , Oftalmopatias/etiologia , Humanos , Hipersecreção Hipofisária de ACTH/complicações , Hipersecreção Hipofisária de ACTH/veterinária , Doenças da Glândula Tireoide/complicações , Doenças da Glândula Tireoide/veterinária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...